Search research articles
Contact Us
Filters
Showing results (11-20 of 128) with videos related to
Page
of 13
Sort By:
Seminars in Hematology
|
July 23, 2014
The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia
Freda K Stevenson, Francesco Forconi, Graham Packham
Exploration of Targeted Anti-Tumor Therapy
|
September 14, 2020
Targeted inhibition of mRNA translation initiation factors as a novel therapeutic strategy for mature B-cell neoplasms
Joe Taylor, Alison M Yeomans, Graham Packham
The International Journal of Biochemistry & Cell Biology
|
October 12, 2004
Mcl-1
Jorg Michels, Peter W M Johnson, Graham Packham
Cancer Genetics and Cytogenetics
|
November 6, 2007
p53 pathway gene single nucleotide polymorphisms and chronic lymphocytic leukemia
Onoshua Lahiri, Scott Harris, Graham Packham, et al.
Organic Letters
|
November 19, 2011
Total synthesis and stereochemical assignment of burkholdac B, a depsipeptide HDAC inhibitor
Hanae Benelkebir, Alison M Donlevy, Graham Packham, et al.
Cancer Medicine
|
June 22, 2018
Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer
Bradleigh Whitton, Haruko Okamoto, Graham Packham, et al.
The International Journal of Biochemistry & Cell Biology
|
October 12, 2004
BAG-1: a multi-functional pro-survival molecule
Paul A Townsend, Anastasis Stephanou, Graham Packham, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
June 11, 2008
Inhibition of proteasomal degradation of Mcl-1 by cobalt chloride suppresses cobalt chloride-induced apoptosis in HCT116 colorectal cancer cells
Melanie Lee, Abigail Lapham, Matthew Brimmell, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 14, 2020
Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors
Rachael Arthur, Beatriz Valle-Argos, Andrew J Steele, et al.
Breast Cancer Research and Treatment
|
June 18, 2010
S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
Annette Hayden, Peter W M Johnson, Graham Packham, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 128) with videos related to
Sort By:
Page
of 13
Seminars in Hematology
|
July 23, 2014
The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia
Freda K Stevenson, Francesco Forconi, Graham Packham
Exploration of Targeted Anti-Tumor Therapy
|
September 14, 2020
Targeted inhibition of mRNA translation initiation factors as a novel therapeutic strategy for mature B-cell neoplasms
Joe Taylor, Alison M Yeomans, Graham Packham
The International Journal of Biochemistry & Cell Biology
|
October 12, 2004
Mcl-1
Jorg Michels, Peter W M Johnson, Graham Packham
Cancer Genetics and Cytogenetics
|
November 6, 2007
p53 pathway gene single nucleotide polymorphisms and chronic lymphocytic leukemia
Onoshua Lahiri, Scott Harris, Graham Packham, et al.
Organic Letters
|
November 19, 2011
Total synthesis and stereochemical assignment of burkholdac B, a depsipeptide HDAC inhibitor
Hanae Benelkebir, Alison M Donlevy, Graham Packham, et al.
Cancer Medicine
|
June 22, 2018
Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer
Bradleigh Whitton, Haruko Okamoto, Graham Packham, et al.
The International Journal of Biochemistry & Cell Biology
|
October 12, 2004
BAG-1: a multi-functional pro-survival molecule
Paul A Townsend, Anastasis Stephanou, Graham Packham, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
June 11, 2008
Inhibition of proteasomal degradation of Mcl-1 by cobalt chloride suppresses cobalt chloride-induced apoptosis in HCT116 colorectal cancer cells
Melanie Lee, Abigail Lapham, Matthew Brimmell, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 14, 2020
Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors
Rachael Arthur, Beatriz Valle-Argos, Andrew J Steele, et al.
Breast Cancer Research and Treatment
|
June 18, 2010
S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
Annette Hayden, Peter W M Johnson, Graham Packham, et al.
Page
of 13